Benil@Iqraa Kidney Care
LightNews LightNews
drbenilhafeeq.bsky.social
Benil@Iqraa Kidney Care
@drbenilhafeeq.bsky.social
77 followers 680 following 0 posts
Nephrologist , Iqraa Kidney Care, Kozhikode, Kerala, India
Posts Replies Media Videos
Reposted by Benil@Iqraa Kidney Care
hswapnil.medsky.social
Missing all the overwhelming amount of science coming out of #KidneyWk?

The #NephJC crew has got you covered

Day 2 edition www.nephjc.com/news/kidneyw... via @nephroseeker.medsky.social & moi
Kidney Week in Houston: Day 2 — NephJC
in this edition: Fish Oil, GBD, Flozination meta-analysis, CHW intervention in Hispanic/Latino patients, and much more
www.nephjc.com
November 8, 2025 at 2:06 PM
Reposted by Benil@Iqraa Kidney Care
hswapnil.medsky.social
Previous #NephJC discussion of felzartamab in transplant ABMR here www.nephjc.com/news/felzart... from @kajareeg.bsky.social and @madihaaziz.bsky.social
Playing It Safe: Can Felzartamab Fill the Gap in AMR Treatment? — NephJC
This week is time antibody mediated rejection treatment in kidney transplant. A new molecule targeting CD38, on the horizon, safely tested in a phase 2 trial
www.nephjc.com
June 26, 2025 at 1:58 PM
Reposted by Benil@Iqraa Kidney Care
ajkd.bsky.social
Stopping Versus Continuing Metformin in Patients With Advanced CKD: A Nationwide Scottish Target Trial Emulation Study

bit.ly/3ZdrYxb #OpenAccess

#VisualAbstract #CKD
April 19, 2025 at 10:01 PM
Reposted by Benil@Iqraa Kidney Care
ajkd.bsky.social
#NephMadness 2025: Minimal Change Disease Region

buff.ly/qk4LG8w

Teams:
- MCD Diagnosis and Pathogenesis
- MCD Relapse

Expert: Susan Samuel
Writers: Mallory Downie & Robert Myette
Execs: Ana Catalina Alvarez-Elías & @nephrosparks.bsky.social
#NephMadness 2025: Minimal Change Disease Region
Submit your picks! | @NephMadness | @nephmadness.bsky.social | NephMadness 2025 Selection Committee Member: Susan Samuel @drsusansamuel Susan Samuel is a Clinician Scientist and Pediatric Nephrolog…
buff.ly
March 1, 2025 at 2:02 PM
Reposted by Benil@Iqraa Kidney Care
hswapnil.medsky.social
Why should HDF produce better vascular access patency?
Observational study, Japan so zero generalizability - nevertheless is there any plausibility to understand beyond the magic of middle molecules and HDF?

academic.oup.com/ndt/advance-... in @ndt-era.bsky.social

#NephSky
Visual abstract
January 29, 2025 at 9:53 PM
Reposted by Benil@Iqraa Kidney Care
katiewiskar.bsky.social
Confession: I LOVE hyponatremia 🤓

(I know, I know. What can I say, I'm a true internist!)

HypoNa is often feared, maligned, and misunderstood - but I promise it doesn't have to be scary!

Here are my top 10 hyponatremia tips and tricks - a 🧵

#emimcc
January 24, 2025 at 2:04 PM
Reposted by Benil@Iqraa Kidney Care
edgarvlermamd.bsky.social
ADPKD: Diagnostic algorithm from @kdigo.org
➖ Family History
#Nephpearls #NephSky

👉 kdigo.org/guidelines/a...
January 22, 2025 at 6:59 PM
Reposted by Benil@Iqraa Kidney Care
edgarvlermamd.bsky.social
Anti-hypertensive agents and their effects on Renin and Aldosterone
#Nephpearls #NephSky

📌 Diuretics and MRAs
⬆️ Renin ⬆️ Aldo

📌 Beta Blockers
⬇️ Renin ⬇️ Aldo

👉🏼 shop.elsevier.com/books/hypert...
Hypertension Secrets
For more than 30 years, the highly regarded Secrets Series® has provided students and practitioners in all areas of health care with concise, foc
shop.elsevier.com
January 18, 2025 at 11:31 PM
Reposted by Benil@Iqraa Kidney Care
ajkd.bsky.social
Frailty in Kidney Disease: A Comprehensive Review to Advance Its Clinical and Research Applications

https://bit.ly/4a7pAvz (FREE)
January 15, 2025 at 11:00 PM
Reposted by Benil@Iqraa Kidney Care
edgarvlermamd.bsky.social
Resistant Hypertension in CKD ca. 2011
#Nephpearls #NephSky

👉 pubmed.ncbi.nlm.nih.gov/33558253/
January 15, 2025 at 11:49 PM